Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs Clobetasol in Alopecia Areata
NCT05885269Phase 1Completed
- Sponsor
- Combined Military Hospital Abbottabad
- Start
- Nov 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Tacrolimus Ointment 0.1% Iwaki in alopecia areata (2 arms), sponsored by Combined Military Hospital Abbottabad. Primary endpoint: Degree of response assessed on the basis of hair regrowth at 6 months. Started Nov 2022; status: completed.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT05885269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05885269.